Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy
Open accessThe DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.
Abstract
Idiopathic inflammatory myopathies (IIMs), which are a group of chronic and diverse inflammatory diseases, are primarily characterized by weakness in the proximal muscles that progressively leads to persistent disability. Current treatments of IIMs depend on nonspecific immunosuppressive agents (including glucocorticoids and immunosuppressants). However, these therapies sometimes fail to regulate muscle inflammation, and some patients suffer from infectious diseases and other adverse effects related to the treatment. Furthermore, even after inflammation has subsided, muscle weakness persists in a significant proportion of the patients. Therefore, the elucidation of pathophysiology of IIMs and development of a better therapeutic strategy that not only alleviates muscle inflammation but also improves muscle weakness without increment of opportunistic infection is awaited. Muscle fiber death, which has been formerly postulated as “necrosis”, is a key histological feature of all subtypes of IIMs, however, its detailed mechanisms and contribution to the pathophysiology remained to be elucidated. Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs). The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness. Furthermore, not only the necroptosis-associated molecules but also PGAM5, a mitochondrial protein, and reactive oxygen species have been shown to be involved in muscle fiber necroptosis, indicating the multiple target candidates for the treatment of IIMs acting through necroptosis regulation. This article overviews the research on muscle injury mechanisms in IIMs focusing on the contribution of necroptosis in their pathophysiology and discusses the potential treatment strategy targeting muscle fiber necroptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next, PF1801 exerts its effects by activating AMP-activated protein kinase (AMPK).382”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [382]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through this sophisticated molecular regulation, PF1801 not only alleviates inflammation and necrosis in muscle fibers but also enhances the energy and antioxidant status of muscle cells.382”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [382]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · cited 1×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundApoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · cited 1×
“Therefore, in addition to the presence of cleaved CASP3, DNA fragmentation, which can be detected using terminal deoxynucleotidyl transferase nick-end labeling (TUNEL) or gel electrophoresis (78, 79), has been widely utilized as a surrogate marker for apoptosis.”
BackgroundGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · cited 18×
“RIPK1 and RIPK3 are cleaved and inactivated by the proteolytic activity of caspases, including CASP8 (118, 119), therefore, inactivation or absence of CASP8 is necessary for the execution of necroptosis.”
BackgroundInfluentialPolymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
SATELLITE CELL OF SKELETAL MUSCLE FIBERS
Mauro, A. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.9.2.493 · Cited by 3,683
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 3×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundMixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549 · cited 1×
“Recent studies have demonstrated the effectiveness of targeting regulated necrosis in models of inflammatory or degenerative diseases (97, 98).”
BackgroundHigh-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1594 · Cited by 2,487
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435 · cited 2×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Human ICE/CED-3 Protease Nomenclature
Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., & Yuan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81334-3 · Cited by 2,372 · cited 5×
“In the 1970s, apoptosis was identified as the first type of RCD (75), which is regulated by caspases (76, 77).”
BackgroundInfluentialIdentification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Mitochondrial fusion and fission in cell life and death
Westermann, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3013 · Cited by 2,002
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L.-F., Wang, F.-S., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,563
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Kaczmarek, A., Vandenabeele, P., & Krysko, D. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.003 · Cited by 1,411
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327 · cited 1×
“PRF1 forms small pores on the postsynaptic cell membrane (99), but the ability of these pores to directly cause cell death is still debated.”
BackgroundPlasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322
Shigella flexneri induces apoptosis in infected macrophages
Zychlinsky, A., Prevost, M. C., & Sansonetti, P. J. (1992) · Nature · doi:10.1038/358167a0 · Cited by 1,262 · cited 1×
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundThe Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220
Linkermann, A., & Green, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1310050 · Cited by 1,103
Filtration, diffusion, and molecular sieving through porous cellulose membranes.
Renkin, E. M. (1954) · PubMed Central · Cited by 1,084
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Hoogendijk, J. E., Amato, A. A., Lecky, B. R., Choy, E. H., Lundberg, I. E., Rose, M. R., Vencovsky, J., de Visser, M., & Hughes, R. A. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.006 · Cited by 950
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
Zhao, J., Jitkaew, S., Cai, Z., Choksi, S., Li, Q., Luo, J., & Liu, Z.-G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200012109 · Cited by 907
Autoimmunity and the Clearance of Dead Cells
Nagata, S., Hanayama, R., & Kawane, K. (2010) · Cell · doi:10.1016/j.cell.2010.02.014 · Cited by 890
Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
Günther, C., Martini, E., Wittkopf, N., Amann, K., Weigmann, B., Neumann, H., Waldner, M. J., Hedrick, S. M., Tenzer, S., Neurath, M. F., et al. (2011) · Nature · doi:10.1038/nature10400 · Cited by 884
Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 836
Dalakas, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1402225 · Cited by 790 · cited 20×
“Injured muscle fibers of patients with PM, DM, including those with anti-TIF1g and anti-ARS antibodies, IBM, and IMNM showed elevated cytoplasmic expression of HMGB1 compared to normal muscle fibers in the same patients (11, 17, 18, 153).”
BackgroundInfluentialLundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40320 · Cited by 730
Schiraldi, M., Raucci, A., Muñoz, L. M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111739 · Cited by 676
Salmonella induces macrophage death by caspase‐1‐dependent necrosis
Brennan, M. A., & Cookson, B. T. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02103.x · Cited by 674
The Cardiovascular Biology of Glucagon-like Peptide-1
Drucker, D. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.009 · Cited by 665
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL
Lawlor, K. E., Khan, N., Mildenhall, A., Gerlic, M., Croker, B. A., D’Cruz, A. A., Hall, C., Kaur Spall, S., Anderton, H., Masters, S. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7282 · Cited by 649
Arahata, K., & Engel, A. G. (1984) · Annals of Neurology · doi:10.1002/ana.410160206 · Cited by 630 · cited 2×
“Histologically, IBM is characterized by the infiltration of CD8 cytotoxic T lymphocytes (CTLs) into the endomysium surrounding and invading non-necrotic muscle fibers (30, 47, 48).”
BackgroundRIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8 + T cells
Yatim, N., Jusforgues-Saklani, H., Orozco, S., Schulz, O., Barreira da Silva, R., Reis e Sousa, C., Green, D. R., Oberst, A., & Albert, M. L. (2015) · Science · doi:10.1126/science.aad0395 · Cited by 622
Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Greenberg, S. A., Pinkus, J. L., Pinkus, G. S., Burleson, T., Sanoudou, D., Tawil, R., Barohn, R. J., Saperstein, D. S., Briemberg, H. R., Ericsson, M., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20464 · Cited by 621
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606
Zhang, Y., Su, S. S., Zhao, S., Yang, Z., Zhong, C.-Q., Chen, X., Cai, Q., Yang, Z.-H., Huang, D., Wu, R., et al. (2017) · Nature Communications · doi:10.1038/ncomms14329 · Cited by 599
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
Rickard, J. A., O’Donnell, J. A., Evans, J. M., Lalaoui, N., Poh, A. R., Rogers, T., Vince, J. E., Lawlor, K. E., Ninnis, R. L., Anderton, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.019 · Cited by 593
HMGB1 is an endogenous immune adjuvant released by necrotic cells
Rovere‐Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I. E., Müller, S., Iannacone, M., Traversari, C., et al. (2004) · EMBO reports · doi:10.1038/sj.embor.7400205 · Cited by 591 · cited 1×
“In contrast, necrosis is characterized by lytic features such as cell swelling, membrane rupture, and absence of DNA fragmentation, resulting in release of intracellular contents including DAMPs and cytokines into the extracellular space, making it a pro-inflammatory form of cell death (76, 81).”
BackgroundActivation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.051 · Cited by 526
Sambrook, P. N., MacGregor, A. J., & Spector, T. D. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<389::aid-anr23>3.0.co;2-p · Cited by 523
Koo, G.-B., Morgan, M. J., Lee, D.-G., Kim, W.-J., Yoon, J.-H., Koo, J. S., Kim, S. I., Kim, S. J., Son, M. K., Hong, S. S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.56 · Cited by 491
Inhibitor of Apoptosis Proteins Limit RIP3 Kinase-Dependent Interleukin-1 Activation
Vince, J. E., Wong, W. W.-L., Gentle, I., Lawlor, K. E., Allam, R., O'Reilly, L., Mason, K., Gross, O., Ma, S., Guarda, G., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.012 · Cited by 491
Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis
Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J., & Marrack, P. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80072-2 · Cited by 482
The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., & Grütter, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206882200 · Cited by 482
Necroptosis activation in Alzheimer's disease
Caccamo, A., Branca, C., Piras, I. S., Ferreira, E., Huentelman, M. J., Liang, W. S., Readhead, B., Dudley, J. T., Spangenberg, E. E., Green, K. N., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4608 · Cited by 482
Linkermann, A., Bräsen, J. H., Himmerkus, N., Liu, S., Huber, T. B., Kunzendorf, U., & Krautwald, S. (2012) · Kidney International · doi:10.1038/ki.2011.450 · Cited by 461
Mariampillai, K., Granger, B., Amelin, D., Guiguet, M., Hachulla, E., Maurier, F., Meyer, A., Tohmé, A., Charuel, J.-L., Musset, L., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2598 · Cited by 455 · cited 13×
“Injured muscle fibers of patients with PM, DM, including those with anti-TIF1g and anti-ARS antibodies, IBM, and IMNM showed elevated cytoplasmic expression of HMGB1 compared to normal muscle fibers in the same patients (11, 17, 18, 153).”
BackgroundInfluentialCleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain
Feng, S., Yang, Y., Mei, Y., Ma, L., Zhu, D.-E., Hoti, N., Castanares, M., & Wu, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.016 · Cited by 446
Microvascular changes in early and advanced dermatomyositis: A quantitative study
Emslie‐Smith, A. M., & Engel, A. G. (1990) · Annals of Neurology · doi:10.1002/ana.410270402 · Cited by 426 · cited 2×
“It has been postulated that the higher prevalence of CD4 T cells in the endomysium of DM might stimulate B lymphocytes to produce autoantibodies, leading to vascular damage and subsequent muscle fiber death (3, 29, 30).”
BackgroundThe structural basis for membrane binding and pore formation by lymphocyte perforin
Law, R. H. P., Lukoyanova, N., Voskoboinik, I., Caradoc-Davies, T. T., Baran, K., Dunstone, M. A., D’Angelo, M. E., Orlova, E. V., Coulibaly, F., Verschoor, S., et al. (2010) · Nature · doi:10.1038/nature09518 · Cited by 414
McHugh, N. J., & Tansley, S. L. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.56 · Cited by 390 · cited 3×
“Although the exact pathogenesis of IIMs has yet to be fully clarified, they are presumed to be auto-immune diseases based on the inflammatory infiltrates in muscle tissues with high frequency of T cells, as well as the common presence of autoantibodies including the myositis-specific autoantibodies (MSAs) such as anti…”
BackgroundBerger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400499 · Cited by 374
Sun, X., Yin, J., Starovasnik, M. A., Fairbrother, W. J., & Dixit, V. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109488200 · Cited by 374
Programmed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos
Robinson, N., Ganesan, R., Hegedűs, C., Kovács, K., Kufer, T. A., & Virág, L. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101239 · Cited by 368
Liu, K., Mori, S., Takahashi, H. K., Tomono, Y., Wake, H., Kanke, T., Sato, Y., Hiraga, N., Adachi, N., Yoshino, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8770com · Cited by 366
Samson, A. L., Zhang, Y., Geoghegan, N. D., Gavin, X. J., Davies, K. A., Mlodzianoski, M. J., Whitehead, L. W., Frank, D., Garnish, S. E., Fitzgibbon, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16887-1 · Cited by 362
Burattini, S., Ferri, P., Battistelli, M., Curci, R., Luchetti, F., & Falcieri, E. (2005) · PubMed · doi:10.4081/891 · Cited by 353
Necroptosis in development and diseases
Shan, B., Pan, H., Najafov, A., & Yuan, J. (2018) · Genes & Development · doi:10.1101/gad.312561.118 · Cited by 347 · cited 15×
“RIPK1 and RIPK3 are cleaved and inactivated by the proteolytic activity of caspases, including CASP8 (118, 119), therefore, inactivation or absence of CASP8 is necessary for the execution of necroptosis.”
BackgroundInfluentialThe Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex
Mompeán, M., Li, W., Li, J., Laage, S., Siemer, A. B., Bozkurt, G., Wu, H., & McDermott, A. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.032 · Cited by 336
Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase
Solomon, J., Swigris, J. J., & Brown, K. K. (2011) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132011000100015 · Cited by 335 · cited 1×
“The patients exhibit a constellation of clinical features known as ASS, including myositis, interstitial lung disease, arthritis, mechanic’s hand, Raynaud phenomenon, and fever, which distinguishes them from DM (39).”
BackgroundClinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy
Watanabe, Y., Uruha, A., Suzuki, S., Nakahara, J., Hamanaka, K., Takayama, K., Suzuki, N., & Nishino, I. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313166 · Cited by 326
Perforin Triggers a Plasma Membrane-Repair Response that Facilitates CTL Induction of Apoptosis
Keefe, D., Shi, L., Feske, S., Massol, R., Navarro, F., Kirchhausen, T., & Lieberman, J. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.001 · Cited by 322 · cited 1×
“They appear to be too small to induce cell death under a physiological condition (100, 101).”
BackgroundLundberg, I. E., de Visser, M., & Werth, V. P. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.41 · Cited by 316 · cited 3×
“IBM is characterized with progressive and sometimes insidious muscle weakness, particularly affecting distal muscles such as the deep finger flexors or tibial anterior (2, 46).”
BackgroundThiery, J., Keefe, D., Boulant, S., Boucrot, E., Walch, M., Martinvalet, D., Goping, I. S., Bleackley, R. C., Kirchhausen, T., & Lieberman, J. (2011) · Nature Immunology · doi:10.1038/ni.2050 · Cited by 314
Nagaraju, K., Raben, N., Loeffler, L., Parker, T., Rochon, P. J., Lee, E., Danning, C., Wada, R., Thompson, C., Bahtiyar, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9209 · Cited by 311 · cited 4×
“Studies using this model have shown that H2K overexpression induces unfolded protein response and endoplasmic reticular stress, resulting in muscle damage and inflammation (24, 67).”
BackgroundMethodInfluentialMareninova, O. A., Sung, K.-F., Hong, P., Lugea, A., Pandol, S. J., Gukovsky, I., & Gukovskaya, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511276200 · Cited by 267
Lopez, J. A., Susanto, O., Jenkins, M. R., Lukoyanova, N., Sutton, V. R., Law, R. H. P., Johnston, A., Bird, C. H., Bird, P. I., Whisstock, J. C., et al. (2013) · Blood · doi:10.1182/blood-2012-07-446146 · Cited by 262
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM
Chahin, N., & Engel, A. G. (2008) · Neurology · doi:10.1212/01.wnl.0000277527.69388.fe · Cited by 258 · cited 1×
“Histologically, IBM is characterized by the infiltration of CD8 cytotoxic T lymphocytes (CTLs) into the endomysium surrounding and invading non-necrotic muscle fibers (30, 47, 48).”
BackgroundGoebels, N., Michaelis, D., Engelhardt, M., Huber, S., Bender, A., Pongratz, D., Johnson, M. A., Wekerle, H., Tschopp, J., Jenne, D., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118749 · Cited by 251 · cited 2×
“Additionally, CD8 CTLs remain in muscles for a prolonged period even after the resolution of the disease (62).”
BackgroundEvaluation and construction of diagnostic criteria for inclusion body myositis
Lloyd, T. E., Mammen, A. L., Amato, A. A., Weiss, M. D., Needham, M., & Greenberg, S. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000642 · Cited by 247 · cited 2×
“The weakness of knee extensors is more pronounced than that of hip flexors (10, 46), and the weakness can be asymmetrical.”
BackgroundSize fractionation of double-stranded DNA by precipitation with polyethylene glycol
Lis, J. T., & Schleif, R. (1975) · Nucleic Acids Research · doi:10.1093/nar/2.3.383 · Cited by 231 · cited 1×
“Therefore, in addition to the presence of cleaved CASP3, DNA fragmentation, which can be detected using terminal deoxynucleotidyl transferase nick-end labeling (TUNEL) or gel electrophoresis (78, 79), has been widely utilized as a surrogate marker for apoptosis.”
BackgroundIdentification of distinctive interferon gene signatures in different types of myositis
Pinal-Fernandez, I., Casal-Dominguez, M., Derfoul, A., Pak, K., Plotz, P., Miller, F. W., Milisenda, J. C., Grau-Junyent, J. M., Selva-O'Callaghan, A., Paik, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008128 · Cited by 230 · cited 1×
“In contrast, IIM patients positive for anti-ARS antibodies show moderate to low expression of MX1 in muscle fibers (34, 35), with their muscle histopathology characterized by the muscle fiber necrosis and regeneration in the perifascicular region (perifascicular necrosis) (37, 38).”
BackgroundInflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients
Suzuki, S., Nishikawa, A., Kuwana, M., Nishimura, H., Watanabe, Y., Nakahara, J., Hayashi, Y. K., Suzuki, N., & Nishino, I. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0277-y · Cited by 227
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1506827 · Cited by 215
Entry and Trafficking of Granzyme B in Target Cells During Granzyme B-Perforin–Mediated Apoptosis
Pinkoski, M. J., Hobman, M., Heibein, J. A., Tomaselli, K., Li, F., Seth, P., Froelich, C. J., & Bleackley, R. C. (1998) · Blood · doi:10.1182/blood.v92.3.1044 · Cited by 214 · cited 9×
“PRF1 forms small pores on the postsynaptic cell membrane (99), but the ability of these pores to directly cause cell death is still debated.”
BackgroundInfluentialBrowne, K. A., Blink, E., Sutton, V. R., Froelich, C. J., Jans, D. A., & Trapani, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8604 · Cited by 208 · cited 1×
“They appear to be too small to induce cell death under a physiological condition (100, 101).”
BackgroundSarcoplasmic redistribution of nuclear TDP‐43 in inclusion body myositis
Salajegheh, M., Pinkus, J. L., Taylor, J. P., Amato, A. A., Nazareno, R., Baloh, R. H., & Greenberg, S. A. (2009) · Muscle & Nerve · doi:10.1002/mus.21386 · Cited by 203
The major human and mouse granzymes are structurally and functionally divergent
Kaiserman, D., Bird, C. H., Sun, J., Matthews, A., Ung, K., Whisstock, J. C., Thompson, P. E., Trapani, J. A., & Bird, P. I. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606073 · Cited by 197 · cited 1×
“GZMB induces cell death via two mechanisms: direct activation of caspases and cleavage of BID, which leads to the activation of mitochondrial cell death pathway (107, 108).”
BackgroundSalajegheh, M., Kong, S. W., Pinkus, J. L., Walsh, R. J., Liao, A., Nazareno, R., Amato, A. A., Krastins, B., Morehouse, C., Higgs, B. W., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21805 · Cited by 197
PREVALENCE OF COXSACKIE B VIRUS ANTIBODIES IN PATIENTS WITH JUVENILE DERMATOMYOSITIS
Christensen, M. L., Pachman, L. M., Schneiderman, R., Patel, D. C., & Friedman, J. M. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291109 · Cited by 193 · cited 1×
“Another study found elevated levels of antibodies against coxsackie B virus in the serum of newly onset cases of juvenile DM (15), implying a potential connection between muscle injury and the development of IIMs.”
BackgroundNecrosis in anti-SRP + and anti-HMGCR + myopathies: Role of autoantibodies and complement
Allenbach, Y., Arouche-Delaperche, L., Preusse, C., Radbruch, H., Butler-Browne, G., Champtiaux, N., Mariampillai, K., Rigolet, A., Hufnagl, P., Zerbe, N., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000004923 · Cited by 193 · cited 1×
“Additionally, the deposition of C5bC9, C1q, HMGCR or SRP, and immunoglobulin G (IgG) on the plasma membrane of non-necrotic muscle fibers (2, 43, 44) is observed.”
BackgroundAmelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
Chen, J., Kos, R., Garssen, J., & Redegeld, F. (2019) · Cells · doi:10.3390/cells8121486 · Cited by 178
Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs
Martens, S., Hofmans, S., Declercq, W., Augustyns, K., & Vandenabeele, P. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.002 · Cited by 176
Bergua, C., Chiavelli, H., Allenbach, Y., Arouche-Delaperche, L., Arnoult, C., Bourdenet, G., Jean, L., Zoubairi, R., Guerout, N., Mahler, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213518 · Cited by 171
Rider, L. G., & Nistala, K. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12444 · Cited by 168 · cited 1×
“DM affects both adults and children, while juvenile DM (JDM) is characterized by systemic vasculopathy and high prevalence of calcinosis (2, 28).”
BackgroundSarcoplasmic MxA expression: A valuable marker of dermatomyositis
Uruha, A., Nishikawa, A., Tsuburaya, R. S., Hamanaka, K., Kuwana, M., Watanabe, Y., Suzuki, S., Suzuki, N., & Nishino, I. (2017) · Neurology · doi:10.1212/wnl.0000000000003568 · Cited by 164 · cited 2×
“In contrast, IIM patients positive for anti-ARS antibodies show moderate to low expression of MX1 in muscle fibers (34, 35), with their muscle histopathology characterized by the muscle fiber necrosis and regeneration in the perifascicular region (perifascicular necrosis) (37, 38).”
BackgroundDuan, X., Liu, X., Liu, N., Huang, Y., Jin, Z., Zhang, S., Ming, Z., & Chen, H. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2328-0 · Cited by 159
Pinal‐Fernandez, I., Casal-Domínguez, M., Derfoul, A., Pak, K. S., Miller, F. W., Milisenda, J. C., Grau‐Junyent, J. M., Selva-O’Callaghan, A., Carrión, C., Paik, J. J., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216599 · Cited by 159
The Molecular Basis for Perforin Oligomerization and Transmembrane Pore Assembly
Baran, K., Dunstone, M. A., Chia, J., Ciccone, A., Browne, K. A., Clarke, C. J. P., Lukoyanova, N., Saibil, H. R., Whisstock, J. C., Voskoboinik, I., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.016 · Cited by 157
Fasth, A. E. R., Dastmalchi, M., Rahbar, A., Salomonsson, S., Pandya, J. M., Lindroos, E., Nennesmo, I., Malmberg, K.-J., Söderberg-Nauclér, C., Trollmo, C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803688 · Cited by 157
The idiopathic inflammatory myopathies: spectrum of MR imaging findings.
Adams, E. M., Chow, C. K., Premkumar, A., & Plötz, P. H. (1995) · Radiographics · doi:10.1148/radiographics.15.3.7624563 · Cited by 139 · cited 1×
“The importance of local muscle conditioning is also evident in human IIMs, as patients exhibit weakness in limited muscle groups and Magnetic resonance imaging (MRI) often shows a patchy distribution pattern of affected muscles while adjacent muscles remain undamaged (72).”
BackgroundNogalska, A., Terracciano, C., D’Agostino, C., King Engel, W., & Askanas, V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0564-6 · Cited by 134
Younce, C. W., Burmeister, M. A., & Ayala, J. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2012 · Cited by 134
Behrens, L. (1997) · Brain · doi:10.1093/brain/120.6.929 · Cited by 129
Meyer, A., LAVERNY, G., Allenbach, Y., Grelet, É., Ueberschlag-Pitiot, V., Echaniz‐Laguna, A., Lannes, B., Alsaleh, G., Charles, A. L., Singh, F., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1731-9 · Cited by 127
Association of inclusion body myositis with T cell large granular lymphocytic leukaemia
Greenberg, S. A., Pinkus, J. L., Amato, A. A., Kristensen, T. K., & Dorfman, D. M. (2016) · Brain · doi:10.1093/brain/aww024 · Cited by 126 · cited 4×
“IBM is associated with an increase in terminally differentiated KLRG CD8 T cells in blood and muscles, which are highly cytotoxic and release proinflammatory cytokines such as IFN-g and TNFa (51, 52).”
BackgroundInfluentialIntegrated classification of inflammatory myopathies
Allenbach, Y., Benvéniste, O., Goebel, H., & Stenzel, W. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12380 · Cited by 123 · cited 1×
“In contrast, IIM patients positive for anti-ARS antibodies show moderate to low expression of MX1 in muscle fibers (34, 35), with their muscle histopathology characterized by the muscle fiber necrosis and regeneration in the perifascicular region (perifascicular necrosis) (37, 38).”
BackgroundMcLoon, L. K., Rowe, J., Wirtschafter, J., & McCormick, K. M. (2004) · Muscle & Nerve · doi:10.1002/mus.20012 · Cited by 118 · cited 1×
“death, minimizing damage within a large muscle fiber (85).”
BackgroundWeisel, K., Scott, N. E., Berger, S. B., Wang, S., Brown, K. A., Powell, M., Broer, M., Watts, C. J., Tompson, D. J., Burriss, S. W., et al. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000680 · Cited by 116
Necroptosis mediates myofibre death in dystrophin-deficient mice
Morgan, J. E., Prola, A., Mariot, V., Pini, V., Meng, J., Hourdé, C., Dumonceaux, J., Conti, F. J. A., Relaix, F., Authier, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06057-9 · Cited by 114
Ulfgren, A., Grundtman, C., Borg, K., Alexanderson, H., Andersson, U., Harris, H. E., & Lundberg, I. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20220 · Cited by 113 · cited 1×
“Injured muscle fibers of patients with PM, DM, including those with anti-TIF1g and anti-ARS antibodies, IBM, and IMNM showed elevated cytoplasmic expression of HMGB1 compared to normal muscle fibers in the same patients (11, 17, 18, 153).”
BackgroundZhou, S., Zhang, W., Cai, G., Ding, Y., Wei, C., Li, S., Yu, Y., Qin, J., Liu, D., Zhang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00393-6 · Cited by 113
Arahata, K., & Engel, A. G. (1988) · Annals of Neurology · doi:10.1002/ana.410230511 · Cited by 108 · cited 1×
“Histologically, PM shares similarities with IBM, including the endomysial infiltration of CD8 CTLs (60) that are dominated by the CD28 subset (61–64), as well as the diffuse MHC class I upregulation on the muscle fibers (4, 53, 65).”
BackgroundThe Inhibition of Apoptosis in Myositis and in Normal Muscle Cells
Nagaraju, K., Casciola-Rosen, L. A., Rosen, A., Thompson, C. D., Loeffler, L., Parker, T., Danning, C. L., Rochon, P. J., Gillespie, J., & Plötz, P. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5459 · Cited by 105
Weisel, K., Berger, S. B., Thorn, K., Taylor, P. C., PETERFY, C. G., Siddall, H. K., Tompson, D. J., Wang, S., Quattrocchi, E., Burriss, S. W., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02468-0 · Cited by 105
Okiyama, N., Sugihara, T., Iwakura, Y., Yokozeki, H., Miyasaka, N., & Kohsaka, H. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24689 · Cited by 101 · cited 1×
“CIM mice develop muscle inflammation and a reduction in muscle strength (17, 25, 68).”
BackgroundMitochondrial ROS prime the hyperglycemic shift from apoptosis to necroptosis
Deragon, M. A., McCaig, W. D., Patel, P., Haluska, R. J., Hodges, A. L., Sosunov, S. A., Murphy, M. P., Ten, V. S., & LaRocca, T. J. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00370-3 · Cited by 101
Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration
De Mori, R., Straino, S., Di Carlo, A., Mangoni, A., Pompilio, G., Palumbo, R., Bianchi, M. E., Capogrossi, M. C., & Germani, A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153429 · Cited by 100
Pinal‐Fernandez, I., Casciola-Rosen, L. A., Christopher‐Stine, L., Corse, A. M., & Mammen, A. L. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.141443 · Cited by 95 · cited 1×
“In contrast, IIM patients positive for anti-ARS antibodies show moderate to low expression of MX1 in muscle fibers (34, 35), with their muscle histopathology characterized by the muscle fiber necrosis and regeneration in the perifascicular region (perifascicular necrosis) (37, 38).”
BackgroundCaproni, M., Torchia, D., Cardinali, C., Volpi, W., Del Bianco, E., D'Agata, A., & Fabbri, P. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06144.x · Cited by 93
Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis
Allenbach, Y., Chaara, W., Rosenzwajg, M., Six, A., Prevel, N., Mingozzi, F., Wanschitz, J., Musset, L., Charuel, J. L., Eymard, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088788 · Cited by 92 · cited 1×
“Frontiers in Immunology 03 by CD28 subset, which is considered to be highly cytotoxic (49, 50).”
BackgroundTemporal summation in muscles and referred pain areas: An experimental human study
Arendt-Nielsen, L., Graven-Nielsen, T., Svensson, P., & Jensen, T. S. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199710)20:10<1311::aid-mus15>3.0.co;2-5 · Cited by 92
Britson, K. A., Ling, J. P., Braunstein, K. E., Montagne, J. M., Kastenschmidt, J. M., Wilson, A., Ikenaga, C., Tsao, W., Pinal‐Fernandez, I., Russell, K. A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi9196 · Cited by 92 · cited 1×
“The effect of T cell depletion on the model was only partially effective, indicating its degenerative nature (58).”
BackgroundWatanabe, Y., Suzuki, S., Nishimura, H., Murata, K., Kurashige, T., Ikawa, M., Asahi, M., Konishi, H., Mitsuma, S., Kawabata, S., et al. (2015) · Medicine · doi:10.1097/md.0000000000000416 · Cited by 91
Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis
Bozec, D., Iuga, A. C., Roda, G., Dahan, S., & Yeretssian, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10135 · Cited by 91
TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis
Zong, M., Bruton, J. D., Grundtman, C., Yang, H., Li, J. H., Alexanderson, H., Palmblad, K., Andersson, U., Harris, H. E., Lundberg, I. E., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202207 · Cited by 90 · cited 4×
“These TLRs are also upregulated on the muscle fibers of patients with IIMs (12).”
BackgroundResultInfluentialNeutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis
Duvvuri, B., Pachman, L. M., Morgan, G. A., Khojah, A. M., Klein‐Gitelman, M. S., Curran, M. L., Doty, S. B., & Lood, C. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41078 · Cited by 89
Weisel, K., Berger, S. B., Papp, K. A., Maari, C., Krueger, J. G., Scott, N. E., Tompson, D. J., Wang, S., Simeoni, M., Bertin, J., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1852 · Cited by 86
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes
González, N., Acitores, A., Sancho, V., Valverde, I., & Villanueva-Peñacarrillo, M. L. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.10.002 · Cited by 85
Wang, L., Wang, T., Li, H., Liu, Q. L., Zhang, Z., Xie, W., Feng, Y., Socorburam, T., Wu, G., Xia, Z., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155723 · Cited by 84
Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury
Chen, H., Cruz, S. A., Qin, Z., & Stewart, A. F. R. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226394 · Cited by 79
Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents
Gurjar, A. A., Kushwaha, S., Chattopadhyay, S., Das, N., Pal, S., China, S. P., Kumar, H., Trivedi, A. K., Guha, R., Chattopadhyay, N., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2019.154044 · Cited by 79
Myonuclear content regulates cell size with similar scaling properties in mice and humans
Hansson, K.-A., Eftestøl, E., Bruusgaard, J. C., Juvkam, I., Cramer, A. W., Malthe-Sørenssen, A., Millay, D. P., & Gundersen, K. (2020) · Nature Communications · doi:10.1038/s41467-020-20057-8 · Cited by 79 · cited 2×
“Multiple nuclei are believed to contribute to mRNA and protein synthesis required for the contractile machinery in muscle fibers (82, 83).”
BackgroundGaiha, G. D., McKim, K. J., Woods, M., Pertel, T., Rohrbach, J., Barteneva, N., Chin, C. R., Liu, D., Soghoian, D. Z., Cesa, K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.011 · Cited by 78
Pandya, J. M., Fasth, A. E. R., Zong, M., Arnardottir, S., Dani, L., Lindroos, E., Malmström, V., & Lundberg, I. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27665 · Cited by 77
Grundtman, C., Bruton, J., Yamada, T., Östberg, T., Pisetsky, D. S., Harris, H. E., Andersson, U., Lundberg, I. E., & Westerblad, H. (2010) · The FASEB Journal · doi:10.1096/fj.09-144782 · Cited by 77
A new murine model to define the critical pathologic and therapeutic mediators of polymyositis
Sugihara, T., Sekine, C., Nakae, T., Kohyama, K., Harigai, M., Iwakura, Y., Matsumoto, Y., Miyasaka, N., & Kohsaka, H. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22521 · Cited by 75 · cited 8×
“Local muscle conditioning with intradermal CFA injection is crucial for inducing myositis in this model, by promoting antigen-presentation for T cells and recruits macrophages that secrete inflammatory cytokines in the muscles (71).”
BackgroundMethodInfluentialShared blood and muscle CD8+ T-cell expansions in inclusion body myositis
Dimitri, D., Benvéniste, O., Dubourg, O., Maisonobe, T., Eymard, B., Amoura, Z., Jean, L., TIEV, K. P., Pietté, J. C., Klatzmann, D., et al. (2006) · Brain · doi:10.1093/brain/awl020 · Cited by 75 · cited 1×
“Clonally expanded CD8 T cells were observed in the peripheral blood and muscles of IBM patients (54), suggesting the involvement of MHC-class I-restricted CTL response.”
BackgroundRIPK3 mediates pathogenesis of experimental ventilator-induced lung injury
Siempos, I. Ι., Ma, K. C., Imamura, M., Baron, R. M., Fredenburgh, L. E., Huh, J. W., Moon, J., Finkelsztein, E. J., Jones, D. S., Lizardi, M. T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97102 · Cited by 75
Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies
Kamiya, M., Mizoguchi, F., Kawahata, K., Wang, D., Nishibori, M., Day, J., Louis, C., Wicks, I. P., Kohsaka, H., & Yasuda, S. (2022) · Nature Communications · doi:10.1038/s41467-021-27875-4 · Cited by 74 · cited 10×
“Meanwhile, PAX7 satellite cells, also known as muscle precursor cells which contribute to muscle regeneration upon injury (146), showed apoptotic feature such as TUNEL positivity (17).”
BackgroundInfluentialSelf-citationTsukamoto, S., Shibasaki, A., Naka, A., Saito, H., & Iida, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113649 · Cited by 71
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
Jhun, J., Lee, S. H., Kim, S. Y., Ryu, J., Kwon, J. Y., Na, H. S., Jung, K., Moon, S., Cho, M., & Min, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1809-3 · Cited by 70
Experimental autoimmune myositis in SJL/J mice.
Rosenberg, N. L., Ringel, S. P., & Kotzin, B. L. (1987) · PubMed · Cited by 65
Schwartz, L. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01887 · Cited by 65 · cited 3×
“Multiple nuclei are believed to contribute to mRNA and protein synthesis required for the contractile machinery in muscle fibers (82, 83).”
BackgroundPredisposing factors in polymyositis-dermatomyositis: results of a nationwide survey.
Lyon, M. G., Bloch, D. A., Hollak, B., & Fries, J. F. (1989) · PubMed · Cited by 64
Soejima, M., Kang, E. H., Gu, X., Katsumata, Y., Clemens, P. R., & Ascherman, D. P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30113 · Cited by 64 · cited 6×
“Antibodies against C frontiersin.org protein are detected in CIM mice, while MSAs are not (25).”
BackgroundInfluentialBurgess, D. H., Svensson, M., Dandrea, T., Grönlund, K., Hammarquist, F., Orrenius, S., & Cotgreave, I. A. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400489 · Cited by 64
Nishio, J., Suzuki, M., Miyasaka, N., & Kohsaka, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4051 · Cited by 64 · cited 1×
“Clonal expansion of CD8 T cells with shared clonotypes in peripheral blood and muscle tissues is also observed in PM patients (66), suggesting a role of CD8 T cells for muscle injury.”
BackgroundCherin, P., Herson, S., Crevon, M., Hauw, J., Cervera, P., Galanaud, P., & Émilie, D. (1996) · PubMed · Cited by 57
Li, M., & Dalakas, M. C. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00162-9 · Cited by 57
Implications of glucocorticoid therapy in idiopathic inflammatory myopathies
Hanaoka, B. Y., Peterson, C. A., Horbinski, C., & Crofford, L. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.85 · Cited by 57 · cited 1×
“Glucocorticoids may further deteriorate muscle weakness through glucocorticoid-induced myopathy (8).”
BackgroundSoponkanaporn, S., Deakin, C. T., Schütz, P. W., Marshall, L. R., Yasin, S. A., Johnson, C. M., Sağ, E., Tansley, S., McHugh, N. J., Wedderburn, L. R., et al. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12498 · Cited by 57
Wilkinson, M. G. L., MOULDING, D. A., McDonnell, T. C. R., Orford, M., Wincup, C., Ting, J. Y. J., Otto, G., Restuadi, R., Kelberman, D., Papadopoulou, C., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223469 · Cited by 57
Du, X., Zhang, H., Zhang, W., Wang, Q., Wang, W., Ge, G., Bai, J., Guo, X., Zhang, Y., Jiang, X., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105732 · Cited by 55
Sugiura, T., Murakawa, Y., Nagai, A., Kondo, M., & Kobayashi, S. (1999) · Arthritis & Rheumatism · Cited by 54
Rojana-udomsart, A., Mitrpant, C., Bundell, C. S., Flynn, L. L., Luo, Y., Fabian, V. A., Wilton, S. D., Hollingsworth, P., & Mastaglia, F. L. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.008 · Cited by 51
Bleecker, J. D., Lundberg, I. E., & de Visser, M. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.07.007 · Cited by 50 · cited 2×
“The weakness of knee extensors is more pronounced than that of hip flexors (10, 46), and the weakness can be asymmetrical.”
BackgroundSiu, P. M., Bryner, R. W., Murlasits, Z., & Alway, S. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00084.2005 · Cited by 50
Pandya, J. M., Venalis, P., Al‐Khalili, L., Hossain, M. S., Stache, V., Lundberg, I. E., Malmström, V., & Fasth, A. E. R. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39650 · Cited by 50
Kamiya, M., Mizoguchi, F., & Yasuda, S. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13025 · Cited by 49
Self-citationMoss, F. P. (1968) · American Journal of Anatomy · doi:10.1002/aja.1001220309 · Cited by 48 · cited 1×
“The “myonuclear domain” theory has been proposed, suggesting that each nucleus regulates its transcriptional activity within a specific cytoplasmic volume of the muscle fiber (82, 84).”
BackgroundPinal‐Fernandez, I., Casciola-Rosen, L. A., Christopher-Stine, L., Corse, A. M., & Mammen, A. L. (2015) · PubMed · Cited by 48
AMP-activated protein kinase protects against necroptosis via regulation of Keap1-PGAM5 complex
Wang, Y.-S., Yu, P., Wang, Y., Zhang, J., Hang, W., Yin, Z.-X., Liu, G., Chen, J., Werle, K. D., Quan, C.-S., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.036 · Cited by 48
Okiyama, N., Ichimura, Y., Shobo, M., Tanaka, R., Kubota, N., Saito, A., Ishitsuka, Y., Watanabe, R., Fujisawa, Y., Nakamura, Y., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218661 · Cited by 48
Lee, S., Kwon, J. Y., Moon, J., Choi, J., Jhun, J., Jung, K., Cho, K.-H., Darlami, O., Lee, H. H., Jung, E. S., et al. (2020) · Immune Network · doi:10.4110/in.2020.20.e16 · Cited by 45
Kleefeld, F., Uruha, A., Schänzer, A., Nishimura, A., Roos, A., Schneider, U., Goebel, H. H., Schuelke, M., Hahn, K., Preuße, C., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201103 · Cited by 44 · cited 4×
“IBM is associated with an increase in terminally differentiated KLRG CD8 T cells in blood and muscles, which are highly cytotoxic and release proinflammatory cytokines such as IFN-g and TNFa (51, 52).”
BackgroundInfluentialSugihara, T., Okiyama, N., Suzuki, M., Kohyama, K., Matsumoto, Y., Miyasaka, N., & Kohsaka, H. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27625 · Cited by 43 · cited 3×
“In the animal experiments on CIM, the absence of PRF1 attenuated the severity of muscle inflammation and the incidence of myositis (69).”
BackgroundInterleukin-23 as a therapeutic target for inflammatory myopathy
Umezawa, N., Kawahata, K., Mizoguchi, F., Kimura, N., Yoshihashi‐Nakazato, Y., Miyasaka, N., & Kohsaka, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-23539-4 · Cited by 41 · cited 1×
“Moreover, the studies on CIM also revealed the crucial role of IL-23 (73) secreted by macrophages and CD80/86 costimulatory factors (74) in muscle inflammation.”
BackgroundSelf-citationNecroptosis may be a novel mechanism for cardiomyocyte death in acute myocarditis
Zhou, F., Jiang, X., Teng, L., Yang, J., Ding, J., & He, C. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3188-5 · Cited by 39
Mitochondria control pyroptosis
Bernard, N. J. (2021) · Nature Immunology · doi:10.1038/s41590-021-01017-w · Cited by 39
Oliv�, M., Martínez‐Matos, J. A., Montero, J., & Ferrer, I. (1997) · Muscle & Nerve · Cited by 38
Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology
Ikenaga, C., Kubota, A., Kadoya, M., Taira, K., Uchio, N., Hida, A., Maeda, M. H., Nagashima, Y., Ishiura, H., Kaida, K., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004333 · Cited by 37 · cited 2×
“Histologically, PM shares similarities with IBM, including the endomysial infiltration of CD8 CTLs (60) that are dominated by the CD28 subset (61–64), as well as the diffuse MHC class I upregulation on the muscle fibers (4, 53, 65).”
BackgroundWoo, M., Chung, S. J., & Nonaka, I. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90211-0 · Cited by 28
Salomonsson, S., Grundtman, C., Zhang, S., Lanner, J. T., Li, C., Katz, A., Wedderburn, L. R., Nagaraju, K., Lundberg, I. E., & Westerblad, H. (2009) · Muscle & Nerve · doi:10.1002/mus.21129 · Cited by 28
Contribution of Necroptosis to Myofiber Death in Idiopathic Inflammatory Myopathies
Peng, Q., Zhang, Y., Liu, Y., Liang, L., Li, W., Tian, X., Zhang, L., Yang, H., Lu, X., & Wang, G. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42071 · Cited by 27 · cited 16×
“In the analysis on the patients with DM and IMNM, the mRNA levels of RIPK3 and MLKL in muscle specimens correlated with indicators of myositis disease activity such as serum CK level and manual muscle testing scores (18).”
BackgroundMethodInfluentialMatsubara, S., Shima, T., & Takamori, M. (1993) · Acta Neuropathologica · doi:10.1007/bf00227760 · Cited by 25
Hedberg‐Oldfors, C., Lindgren, U., Visuttijai, K., Lööf, D., Roos, S., Thomsen, C., & Oldfors, A. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12841 · Cited by 24
Kamiya, M., Mizoguchi, F., Takamura, A., Kimura, N., Kawahata, K., & Kohsaka, H. (2019) · Lara D. Veeken · doi:10.1093/rheumatology/kez248 · Cited by 23
Self-citationWan, Z., Zhang, X., Peng, A., He, M. Y., Lei, Z., & Wang, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.10.009 · Cited by 22
Kimura, N., Hirata, S., Miyasaka, N., Kawahata, K., & Kohsaka, H. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39017 · Cited by 20 · cited 1×
“In CIM, muscle fiber death induced by the intramuscular injection of bupivacaine hydrochloride (BPVC), a local anesthetic, can induce local muscle inflammation and even facilitate the relapse of myositis in mice preimmunized with C protein fragment (13).”
BackgroundSelf-citationPaepe, B. D., & Bleecker, J. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.064 · Cited by 19
Myoinjury transiently activates muscle antigen–specific CD8+ T cells in lymph nodes in a mouse model
Liao, H., Franck, E., Fréret, M., Adriouch, S., Baba‐Amer, Y., Authier, F., Boyer, O., & Gherardi, R. K. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34551 · Cited by 19 · cited 1×
“In vivo analysis on the mice expressing ovalbumin in their muscles showed that muscle injury led to the proliferation of ovalbuminspecific T lymphocytes (16), suggesting that cell death of muscle fibers could supply intracellular autoantigens and activate immune system (7).”
BackgroundMa, M., Chai, K.-X., & Deng, R. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107810 · Cited by 19
Liu, M., Li, L., Dai, T., Hou, Y., Li, W., Zhao, Y., Fang, Q., & Yan, C. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa023 · Cited by 18
T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model
Okiyama, N., Sugihara, T., Oida, T., Ohata, J., Yokozeki, H., Miyasaka, N., & Kohsaka, H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34629 · Cited by 17 · cited 2×
“Local muscle conditioning with intradermal CFA injection is crucial for inducing myositis in this model, by promoting antigen-presentation for T cells and recruits macrophages that secrete inflammatory cytokines in the muscles (71).”
BackgroundTomimitsu, H., Ohta, A., Nagai, M., Nishina, M., Ishihara, S., & Kohsaka, H. (2015) · Modern Rheumatology · doi:10.3109/14397595.2015.1091137 · Cited by 17 · cited 1×
“Moreover, muscle weakness remains persistent in over half of IIM patients even after the settlement of muscle inflammation (9).”
BackgroundAberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies
Day, J. A., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., Limaye, V. S., & Hayball, J. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00226 · Cited by 17
Okiyama, N., Hasegawa, H., Oida, T., Hirata, S., Yokozeki, H., Fujimoto, M., Miyasaka, N., & Kohsaka, H. (2015) · International Immunology · doi:10.1093/intimm/dxv001 · Cited by 13 · cited 1×
“CTLs play a crucial role in muscle injury of CIM (25, 69, 70).”
BackgroundSelf-citationHasegawa, H., Kawahata, K., Mizoguchi, F., Okiyama, N., Miyasaka, N., & Kohsaka, H. (2017) · PubMed · Cited by 8
Self-citationScalabrini, J. C., Schiffenbauer, A. I., Farhadi, P. N., Volochayev, R., Bayat, N., Jansen, A., Targoff, I. N., Miller, F. W., & Rider, L. G. (2022) · Pediatric Rheumatology · doi:10.1186/s12969-022-00684-9 · Cited by 7
[Fas antigen is expressed in human diseased muscles, but does not link to apoptosis].
Inukai, A., Kobayashi, Y., Honda, H., & Sobue, G. (1996) · PubMed · Cited by 3
Research works printed but not linked: 1
- 39. Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol (2013) 37:100-9. doi: 10.1590/S1806- 37132011000100015 · doi:10.1590/s1806-
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Diabetes-induced muscle wasting: molecular mechanisms and promising therapeutic targets
Qiao, R., Guo, J., Zhang, C., Wang, S., Fang, J., Geng, R., Kang, S., Huang, K., & Tong, T. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2382348 · Cited by 18
“In addition to ferroptosis, other forms of regulated necrosis, such as pyro-ptosis and necroptosis, have also been associated with muscle wasting (Jin et al. 2022; Kamiya et al. 2023).”
Gong, J., Hong-yi, X., Shen, Y., Gao, Z., Ji, Y., Yao, X., Sun, J., Dai, B., & Sun, H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179208 · Cited by 10
Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
Nasonov, E. L., Паневин, Т. С., & Troshina, E. A. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-135-144 · Cited by 8
The role of cell death in the physiological and pathological processes of skeletal muscle
Hong-yi, X., Gao, Z., Yao, X., Sun, J., & Chen, B. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1717233 · Cited by 10
Metadata
- Authors
- Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S.
- Affiliations
- Tokyo Medical and Dental University (JP)
- Corresponding author
- Yasuda, Shinsuke
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-07-07
- Volume
- 14
- Pages
- 1191815-1191815
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC10361824
- OpenAlex
- W4383534034
- Cited by
- 21
- References
- 193
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 5
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Inflammatory Myopathies and Dermatomyositis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- idiopathic inflammatory myopathies, polymyositis, HMGB1, damage-associated molecular patterns, PGAM5, reactive oxygen species, muscle inflammation, muscle weakness, regulated cell death, therapeutic target
- MeSH terms
- Necroptosis, Animals, Humans, Inflammation, Myositis, Muscle Fibers, Skeletal, Muscle Weakness, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.